ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

New Screening Tool Helps GP ID Hereditary BC Risk

October 27, 2006

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

February 13, 1998

MRI Predicts If Chemo Working In Preoperative Therapy

February 25, 2005

NIH Dedicates Louis Stokes Laboratories; Royston Retires As Kimmel Center President.

June 22, 2001

Von Eschenbach Takes NCI’s Helm As Bush Proposes Budget Increase.

February 8, 2002

In Brief: Hatch Bill Would Relax Delaney Clause; Malone Names Acting NIH Head; Search Committee Formed

July 17, 1981